Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.1386-3.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 883.93M | 900.13M | 931.56M | 957.43M | 997.85M |
| Total Other Revenue | 17.84M | 17.84M | 13.05M | 16.19M | 13.34M |
| Total Revenue | 901.77M | 917.97M | 944.61M | 973.63M | 1.01B |
| Cost of Revenue | 612.74M | 606.04M | 592.40M | 600.19M | 625.84M |
| Gross Profit | 289.03M | 311.93M | 352.21M | 373.44M | 385.35M |
| SG&A Expenses | 135.81M | 135.39M | 128.90M | 127.62M | 122.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.33M | 3.07M | 4.25M | 3.34M | 1.36M |
| Total Operating Expenses | 784.23M | 777.63M | 758.64M | 766.90M | 786.21M |
| Operating Income | 117.53M | 140.34M | 185.97M | 206.73M | 224.97M |
| Income Before Tax | 61.71M | 92.43M | 175.29M | 218.60M | 311.50M |
| Income Tax Expenses | 27.78M | 30.09M | 32.74M | 38.75M | 45.64M |
| Earnings from Continuing Operations | 33.93 | 62.35 | 142.55 | 179.85 | 265.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.44M | -5.98M | -9.31M | -23.56M | -28.16M |
| Net Income | 46.37M | 56.36M | 133.24M | 156.28M | 237.69M |
| EBIT | 117.53M | 140.34M | 185.97M | 206.73M | 224.97M |
| EBITDA | 145.17M | 167.36M | 212.27M | 232.04M | 249.53M |
| EPS Basic | 0.05 | 0.06 | 0.15 | 0.18 | 0.27 |
| Normalized Basic EPS | 0.11 | 0.11 | 0.15 | 0.16 | 0.17 |
| EPS Diluted | 0.05 | 0.06 | 0.15 | 0.18 | 0.27 |
| Normalized Diluted EPS | 0.11 | 0.11 | 0.15 | 0.16 | 0.17 |
| Average Basic Shares Outstanding | 3.45B | 3.45B | 3.46B | 3.46B | 3.47B |
| Average Diluted Shares Outstanding | 3.45B | 3.45B | 3.46B | 3.46B | 3.47B |
| Dividend Per Share | 0.04 | 0.04 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 192.19% | 158.99% | 65.76% | 53.23% | 33.61% |